Information Provided By:
Fly News Breaks for May 12, 2016
PBMD
May 12, 2016 | 10:31 EDT
Maxim raised Buy rated Prima BioMed's price target to $5 due to increased confidence in CVac immuno-oncology program success.
News For PBMD From the Last 2 Days
There are no results for your query PBMD